Header Logo

Connection

MICHAEL JOHNSON to Aged

Back to Details
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Aged.
MICHAEL JOHNSON
Connection Strength
1.306
Aged
  1. Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study. J Geriatr Oncol. 2024 11; 15(8):102071.
    View in: PubMed
    Score: 0.065
  2. Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer in the United States: A SEER-Medicare population-based study. Cancer. 2023 04 01; 129(7):1051-1063.
    View in: PubMed
    Score: 0.058
  3. Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+/HER2- metastatic breast cancer in the United States. Breast Cancer Res Treat. 2023 Feb; 198(1):159-166.
    View in: PubMed
    Score: 0.058
  4. Patterns of Lipid Lowering Therapy Use Among Older Adults in a Managed Care Advantage Plan in the United States. J Pharm Pract. 2024 Feb; 37(1):123-131.
    View in: PubMed
    Score: 0.057
  5. Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes. Breast Cancer Res Treat. 2022 Oct; 195(3):421-430.
    View in: PubMed
    Score: 0.056
  6. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer. Cancer. 2019 04 01; 125(7):1155-1162.
    View in: PubMed
    Score: 0.044
  7. Regression coefficient-based scoring system should be used to assign weights to the risk index. J Clin Epidemiol. 2016 11; 79:22-28.
    View in: PubMed
    Score: 0.037
  8. Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension. J Alzheimers Dis. 2016; 49(2):423-32.
    View in: PubMed
    Score: 0.036
  9. Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. Am J Alzheimers Dis Other Demen. 2016 08; 31(5):395-404.
    View in: PubMed
    Score: 0.036
  10. Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study. Drugs Aging. 2015 Sep; 32(9):743-54.
    View in: PubMed
    Score: 0.035
  11. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement. 2012 Sep; 8(5):437-44.
    View in: PubMed
    Score: 0.028
  12. Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failure. J Comp Eff Res. 2012 Mar; 1(2):195-206.
    View in: PubMed
    Score: 0.027
  13. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):233-40.
    View in: PubMed
    Score: 0.026
  14. Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure: a multiple-propensity analysis. Res Social Adm Pharm. 2012 Mar-Apr; 8(2):145-56.
    View in: PubMed
    Score: 0.026
  15. Risk factors for dementia in patients over 65 with diabetes. Int J Geriatr Psychiatry. 2011 Jul; 26(7):749-57.
    View in: PubMed
    Score: 0.025
  16. The association of Medicare drug coverage with use of evidence-based medications in the Veterans Health Administration. Ann Pharmacother. 2009 Oct; 43(10):1565-75.
    View in: PubMed
    Score: 0.023
  17. VHA pharmacy use in veterans with Medicare drug coverage. Am J Manag Care. 2009 Mar 16; 15(3):e1-8.
    View in: PubMed
    Score: 0.022
  18. Propensity score analysis in observational studies: outcomes after abdominal aortic aneurysm repair. Am J Surg. 2006 Sep; 192(3):336-43.
    View in: PubMed
    Score: 0.019
  19. Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care. 2006 Aug; 44(8):793-7.
    View in: PubMed
    Score: 0.019
  20. Therapeutic goal attainment in patients with hypertension and dyslipidemia. Med Care. 2006 Jan; 44(1):39-46.
    View in: PubMed
    Score: 0.018
  21. Patterns of antihypertensive therapy among patients with diabetes. J Gen Intern Med. 2005 Sep; 20(9):842-6.
    View in: PubMed
    Score: 0.017
  22. Prescribing patterns of diuretics in multi-drug antihypertensive regimens. J Clin Hypertens (Greenwich). 2005 Feb; 7(2):81-7; quiz 88-9.
    View in: PubMed
    Score: 0.017
  23. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease. Am J Manag Care. 2004 Dec; 10(12):926-32.
    View in: PubMed
    Score: 0.017
  24. Real-world treatment patterns in drug na?ve type 2 diabetes population: Initial combination therapy vs. sequential step-therapy. J Am Pharm Assoc (2003). 2025 Jan-Feb; 65(1):102295.
    View in: PubMed
    Score: 0.016
  25. Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas. Patient Educ Couns. 2024 Feb; 119:108073.
    View in: PubMed
    Score: 0.015
  26. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Drugs Aging. 2023 04; 40(4):377-390.
    View in: PubMed
    Score: 0.015
  27. Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling. Pharmacotherapy. 2022 07; 42(7):518-528.
    View in: PubMed
    Score: 0.014
  28. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study. Drugs Aging. 2022 06; 39(6):453-465.
    View in: PubMed
    Score: 0.014
  29. Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1351-1358.
    View in: PubMed
    Score: 0.014
  30. Risk of overactive bladder associated with cholinesterase inhibitors in dementia. J Am Geriatr Soc. 2022 03; 70(3):820-830.
    View in: PubMed
    Score: 0.013
  31. Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study. Curr Med Res Opin. 2021 08; 37(8):1303-1313.
    View in: PubMed
    Score: 0.013
  32. Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study. Drugs Aging. 2021 06; 38(6):493-502.
    View in: PubMed
    Score: 0.013
  33. Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder. Int J Geriatr Psychiatry. 2021 05; 36(5):684-696.
    View in: PubMed
    Score: 0.013
  34. Concordance Between Electronic Health Record Data and Medicare Part D Claims Data for Oral Anticancer Drug Use. JAMA Netw Open. 2020 04 01; 3(4):e203821.
    View in: PubMed
    Score: 0.012
  35. Impact of Chlorhexidine Bathing on Antimicrobial Utilization in Surgical Intensive Care Unit. J Surg Res. 2020 06; 250:161-171.
    View in: PubMed
    Score: 0.012
  36. Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease. Am J Geriatr Psychiatry. 2020 10; 28(10):1079-1088.
    View in: PubMed
    Score: 0.012
  37. Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study. J Gen Intern Med. 2020 07; 35(7):2084-2093.
    View in: PubMed
    Score: 0.012
  38. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence. J Manag Care Spec Pharm. 2019 Oct; 25(10):1053-1062.
    View in: PubMed
    Score: 0.012
  39. Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson's disease. J Psychiatr Res. 2019 10; 117:116-121.
    View in: PubMed
    Score: 0.011
  40. Patient-reported outcomes in light of supportive medications in treatment-na?ve lung cancer patients. Support Care Cancer. 2020 Apr; 28(4):1809-1816.
    View in: PubMed
    Score: 0.011
  41. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression. Res Social Adm Pharm. 2020 03; 16(3):329-335.
    View in: PubMed
    Score: 0.011
  42. Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression. Drugs Aging. 2017 09; 34(9):691-700.
    View in: PubMed
    Score: 0.010
  43. The Prevalence of and Factors Associated With Receiving Concurrent Controlled Substance Prescriptions. Subst Use Misuse. 2017 Oct 15; 52(12):1639-1645.
    View in: PubMed
    Score: 0.010
  44. Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine. Pharmacotherapy. 2017 03; 37(3):287-296.
    View in: PubMed
    Score: 0.010
  45. Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression. Am J Alzheimers Dis Other Demen. 2016 12; 31(8):678-686.
    View in: PubMed
    Score: 0.009
  46. Discharge medication complexity and 30-day heart failure readmissions. Res Social Adm Pharm. 2017 Jul - Aug; 13(4):857-863.
    View in: PubMed
    Score: 0.009
  47. Effect of Chlorhexidine Bathing Every Other Day on Prevention of Hospital-Acquired Infections in the Surgical ICU: A Single-Center, Randomized Controlled Trial. Crit Care Med. 2016 Oct; 44(10):1822-32.
    View in: PubMed
    Score: 0.009
  48. Comparative risk of hip fractures in elderly nursing home patients with depression using paroxetine and other selective serotonin reuptake inhibitors. J Comp Eff Res. 2016 08; 5(5):461-73.
    View in: PubMed
    Score: 0.009
  49. Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression. J Am Geriatr Soc. 2016 07; 64(7):1492-7.
    View in: PubMed
    Score: 0.009
  50. Comparative Performance of Diagnosis-based and Prescription-based Comorbidity Scores to Predict Health-related Quality of Life. Med Care. 2016 May; 54(5):519-27.
    View in: PubMed
    Score: 0.009
  51. Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression. Am J Geriatr Psychiatry. 2016 06; 24(6):485-95.
    View in: PubMed
    Score: 0.009
  52. Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study. J Am Geriatr Soc. 2016 Feb; 64(2):394-400.
    View in: PubMed
    Score: 0.009
  53. Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression. Pharmacotherapy. 2016 Jan; 36(1):38-48.
    View in: PubMed
    Score: 0.009
  54. Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression. Ann Pharmacother. 2016 Feb; 50(2):96-105.
    View in: PubMed
    Score: 0.009
  55. Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers. Subst Use Misuse. 2015; 50(13):1628-37.
    View in: PubMed
    Score: 0.009
  56. Potentially inappropriate anticholinergic medication use in older adults with dementia. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):603-612.
    View in: PubMed
    Score: 0.009
  57. Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors. Psychiatr Serv. 2015 Dec 01; 66(12):1333-40.
    View in: PubMed
    Score: 0.009
  58. Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study. Drugs Aging. 2015 May; 32(5):379-89.
    View in: PubMed
    Score: 0.009
  59. CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study. Am J Clin Oncol. 2015 Apr; 38(2):165-73.
    View in: PubMed
    Score: 0.008
  60. Administrative databases, case-mix adjustments and hospital resource use: the appropriateness of controlling patient characteristics. J Clin Epidemiol. 1995 Mar; 48(3):423-30.
    View in: PubMed
    Score: 0.008
  61. Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study. Drugs Aging. 2012 Oct; 29(10):807-17.
    View in: PubMed
    Score: 0.007
  62. Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study. Am J Geriatr Pharmacother. 2012 Apr; 10(2):83-94.
    View in: PubMed
    Score: 0.007
  63. A model to predict mortality following Pseudomonas aeruginosa bacteremia. Diagn Microbiol Infect Dis. 2012 Jan; 72(1):97-102.
    View in: PubMed
    Score: 0.007
  64. Effect of bar-code-assisted medication administration on nurses' activities in an intensive care unit: a time-motion study. Am J Health Syst Pharm. 2011 Jun 01; 68(11):1026-31.
    View in: PubMed
    Score: 0.006
  65. Risk of serious cardiac events in older adults using antipsychotic agents. Am J Geriatr Pharmacother. 2011 Apr; 9(2):120-32.
    View in: PubMed
    Score: 0.006
  66. Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. Drugs Aging. 2010 Oct 01; 27(10):815-29.
    View in: PubMed
    Score: 0.006
  67. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. J Clin Psychiatry. 2010 Jun; 71(6):689-98.
    View in: PubMed
    Score: 0.006
  68. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010 May 06; 5:125-32.
    View in: PubMed
    Score: 0.006
  69. Does diabetes mellitus alter the onset and clinical course of vascular dementia? Behav Neurol. 2010; 23(3):145-51.
    View in: PubMed
    Score: 0.006
  70. Depression and anxiety in ambulatory patients with heart failure. Psychosomatics. 2009 Nov-Dec; 50(6):592-8.
    View in: PubMed
    Score: 0.006
  71. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatr Pharmacother. 2009 Oct; 7(5):250-61.
    View in: PubMed
    Score: 0.006
  72. Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol. 2009 May; 104(5):1241-8.
    View in: PubMed
    Score: 0.006
  73. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009 May; 136(5):1601-8.
    View in: PubMed
    Score: 0.006
  74. Generalized anxiety disorder in older medical patients: diagnostic recognition, mental health management and service utilization. J Clin Psychol Med Settings. 2009 Jun; 16(2):178-85.
    View in: PubMed
    Score: 0.006
  75. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Am J Geriatr Pharmacother. 2008 Oct; 6(4):198-204.
    View in: PubMed
    Score: 0.005
  76. Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004. Curr Med Res Opin. 2008 Mar; 24(3):709-16.
    View in: PubMed
    Score: 0.005
  77. Antipsychotic utilization and expenditure trends among elderly persons. Psychiatr Serv. 2007 Nov; 58(11):1400.
    View in: PubMed
    Score: 0.005
  78. Performance of endovascular aortic aneurysm repair in high-risk patients: results from the Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg. 2007 Feb; 45(2):227-233; discussion 233-5.
    View in: PubMed
    Score: 0.005
  79. Open versus endovascular abdominal aortic aneurysm repair in VA hospitals. J Am Coll Surg. 2006 Apr; 202(4):577-87.
    View in: PubMed
    Score: 0.005
  80. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology. 2005 Oct; 129(4):1171-8.
    View in: PubMed
    Score: 0.004
  81. Mortality after noncardiac surgery: prediction from administrative versus clinical data. Med Care. 2005 Feb; 43(2):159-67.
    View in: PubMed
    Score: 0.004
  82. Lower extremity nontraumatic amputation among veterans with peripheral arterial disease: is race an independent factor? Med Care. 2002 Jan; 40(1 Suppl):I106-16.
    View in: PubMed
    Score: 0.003
  83. Preoperative risk factors for 30-day mortality after elective surgery for vascular disease in Department of Veterans Affairs hospitals: is race important? J Vasc Surg. 2001 Oct; 34(4):634-40.
    View in: PubMed
    Score: 0.003
  84. The association of quality of care and occurrence of in-hospital, treatment-related complications. Med Care. 1999 Feb; 37(2):140-8.
    View in: PubMed
    Score: 0.003
  85. Expected source of payment and use of hospital services for coronary atherosclerosis. Med Care. 1995 Jul; 33(7):715-28.
    View in: PubMed
    Score: 0.002
  86. In-hospital complications among survivors of admission for congestive heart failure, chronic obstructive pulmonary disease, or diabetes mellitus. J Gen Intern Med. 1995 Jun; 10(6):307-14.
    View in: PubMed
    Score: 0.002
  87. The association between the quality of inpatient care and early readmission. Ann Intern Med. 1995 Mar 15; 122(6):415-21.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.